Status:
TERMINATED
Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
Thrasher Research Fund
Conditions:
Autism
Pervasive Developmental Disorder
Eligibility:
All Genders
3-8 years
Phase:
PHASE1
Brief Summary
There are two phases to the study. The first will examine serum copper and zinc levels and copper/zinc ratio in children (ages 3-8) who have autism and compare them to levels from same sex and age chi...
Eligibility Criteria
Inclusion
- Ages 3-8 years
- Diagnosis of autism spectrum disorder
- Serum copper/zinc ratio greater than 2.0 or as determined in phase 1 of the study
Exclusion
- Known chromosomal disorder or neurological disorders other than autism
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT00325572
Start Date
November 1 2006
End Date
December 1 2011
Last Update
July 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Children's Hospital
Hershey, Pennsylvania, United States, 17033